Reliable Data You Can Trust
Reliable Data You Can Trust
A recent report published by Infinium Global Research on alopecia drugs market provides in-depth analysis of segments and sub-segments in global as well as regional alopecia drugs market. The study also highlights the impact of drivers, restraints and macro indicators on the global and regional alopecia drugs market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global alopecia drugs market. According to the report the global alopecia drugs market is projected to grow at a CAGR of 7.2% over the forecast period of 2018-2024.
Alopecia is a Latin word that refers to hair loss and scientifically, it is known as Androgenic Alopecia. This is a genetic hair loss condition that occurs in both male and female as pattern baldness and pattern hair loss. Globally, numerous people are suffering from hair losses. The most common types of alopecia include alopecia areata, alopecia totalis, alopecia universalis and so on. Mainly, alopecia is a genetic condition but it can also occur due to the fungal infection, serious health problem and unhealthy conditions of the scalp. Alopecia drugs are used to treat the diverse conditions of hair loss.
Genetics is one of the major factor driving the growth of alopecia drugs market across the globe. The rising prevalence of cancer and its treatment methods such as chemotherapy leads to heavy hair loss that results in the increasing demand for hair loss therapies. In addition, the rising acceptance of alopecia drug across the world, rapidly changing lifestyle leading to physical inactivity and increase work stress among employees can results in hair falls. Factors such as fewer side effects of alopecia drugs and enhanced effectiveness for treatments are some factors that contribute to the growth of alopecia market.
However, the high cost of medication is hampering the growth of alopecia drug market. Moreover, ongoing research and developments by the healthcare expertise to increase the performance and efficiency of the drug are projected to create more opportunities in upcoming years.
North America is expected to dominate the market of alopecia drug over the forecast period of 2018 to 2024. The North America government supports and favors innovation of new drugs, The hectic lifestyle of population results in rising in the occurrence of hair fall cases which is expected to escalate the market growth ofalopecia drugs in the North America region. In addition, the Asia-Pacific region is expected to grow at the fastest CAGR in the alopecia drugs market due to the increasing population and rising healthcare expenditures for new innovative treatments.
The report on global alopecia drugs market covers segments such as alopecia types, route of administration (ROA) and gender. On the basis of alopecia types the global alopecia drugs market is categorized into alopecia areata, alopecia totalis, alopecia universalis, and others. On the basis of route of administration (ROA) the global alopecia drugs market is categorized into oral, topical and injectable. On the basis of gender, the global alopecia drugs market is categorized into men and women.
The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section, the key trends and market size for each geography are provided over the period of 2016-2024. The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience growth at a CAGR of x.x% over the period of 2018-2024.
The report provides profiles of the companies in the global alopecia drugs market such as GlaxoSmithKline, Johnson & Johnson, Cipla Inc., Dr. Reddy’s Laboratories Ltd, Merck, Aqua Pharmaceuticals, Bayer HealthCare, AndroScience, Helix BioMedix, The Himalaya Drug Company, and others.
The report provides deep insights on demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the global alopecia drugs market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of alopecia drugs market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the alopecia drugs market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players. This report will help manufacturers, suppliers, and distributors of the alopecia drugs market to understand the present and future trends in this market and formulate their strategies accordingly.
Please Choose One of them.